Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Joint Development Agreement - MSC Shipmanagement

21 Jan 2021 07:00

RNS Number : 3888M
Quadrise Fuels International PLC
21 January 2021
 

21 January 2021

 

Quadrise Fuels International plc

("Quadrise", "QFI" or the "Company")

 

 

JOINT DEVELOPMENT AGREEMENT WITH MSC SHIPMANAGEMENT LIMITED

 

Quadrise is pleased to announce it has signed a Joint Development Agreement ("JDA") with MSC Shipmanagement Limited of Cyprus ("MSC"), a 100% subsidiary of MSC Mediterranean Shipping Company SA headquartered in Geneva, to carry out an MSAR® Operational Trial (the "Trial") on commercial container vessels in the MSC global fleet commencing in 2021 with, subject to further agreement, subsequent commercial rollout upon success. The MSC Group is one of the world's largest cargo shipping and cruise line companies.

 

Initial activities under the JDA will include project initiation, definition, high-level scoping and feasibility activities ("Initial Activities") of the overall Trial. The Initial Activities are to be completed within 3 months.

 

Contingent on the outcome of the Initial Activities the parties will progress and define the project roadmap during Q2'21 in preparation for the execution of one or more Trials commencing in H2'21 on representative commercial vessels in MSC's global fleet ("Phase 1"). Upon completion and success of Phase 1, and subject to further agreement between the parties, the JDA envisages subsequent commercial roll-out across the MSC global fleet ("Phase 2").

 

Phase 1 will see the testing of MSAR® fuel in a large MAN ME and/or a Wärtsilä/WinGD Flex 2-stroke engine so as to obtain Letter Of No Objection ("LONO") approvals from the respective engine manufacturers. Phase 1 testing may also incorporate testing of QFI's new bioMSARTM biofuel.

 

In the event that the Trial(s) and LONO approval(s) are successful under Phase 1, and subject to further commercial agreements to be agreed between the parties, the parties would seek to rollout MSAR® fuel, and potentially bioMSARTM, for the MSC global fleet.

 

The JDA will capitalise on QFI's skills in emulsion fuel application and use in large diesel engines. MSC will contribute its vast shipping industry experience and provide technical expertise relating to naval architecture, machinery systems, fuels, exhaust gas cleaning systems, emissions and technical ship management. MSC is at the forefront of exploring and trialling fuels and technologies to help decarbonise the international shipping industry.

Commenting on this agreement Jason Miles, CEO of QFI, said:

"Quadrise is delighted to have signed this agreement with MSC and we look forward to working alongside them to progress this excellent opportunity. We believe that MSC's large modern fleet installed with electronic engines and, in some cases, exhaust gas cleaning systems (scrubbers) is well positioned to realise the economic and environmental benefits of MSAR® and bioMSARTM and we look forward to realising the project and getting the trials underway in 2021."

Commenting on this agreement Prabhat Jha, Group MD & CEO of MSC Shipmanagement Ltd, said:

"MSC is looking forward to working with the Quadrise team under the JDA in 2021 to scope out the operational trials of MSAR® on our container vessels. We are particularly interested in the potential environmental benefits of MSAR® and bioMSARTM that, alongside the economic benefits, reflect our approach to operating a modern MSC fleet, and fit well with our overall future fuels strategy."

 

 

For further information, please contact:

 

Quadrise Fuels International Plc

 

Mike Kirk, Chairman

+44 (0)20 7031 7321

Jason Miles, Chief Executive Officer

ir@quadrisefuels.com

 

 

Nominated Adviser

 

Cenkos Securities plc

 

Ben Jeynes

Katy Birkin

+44 (0)20 7397 8900

 

 

Joint Brokers

 

Peel Hunt LLP

 

Richard Crichton

+44 (0)20 7418 8900

David McKeown

 

 

 

Shore Capital Stockbrokers Limited

 

Toby Gibbs

Fiona Conroy

+44 (0)20 7408 4090

 

 

Public & Investor Relations

 

FTI Consulting

 

Ben Brewerton

+44 (0)20 3727 1000

Ntobeko Chidavaenzi

 

 

The information communicated within this announcement was deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 prior to the release of this announcement. Upon the publication of this announcement, this inside information is now considered to be in the public domain. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREAAFEAFFFEAA
Date   Source Headline
7th Oct 20197:00 amRNSFinal Results for the year ended 30 June 2019
2nd Oct 201911:42 amRNSTotal Voting Rights
30th Sep 20197:18 amRNSResult of Open Offer
27th Sep 20194:09 pmRNSIssue of Warrants
27th Sep 20192:03 pmRNSResult of General Meeting
9th Sep 20197:00 amRNSOpen Offer, Subscription and Notice of GM
6th Sep 20193:00 pmRNSWebsite Update
30th Aug 20195:07 pmRNSIssue of Convertible Security
27th Aug 20197:00 amRNSInvestor Conference Call
23rd Aug 20197:00 amRNSConvertible Securities, Issue of Equity & Warrants
19th Aug 20197:00 amRNSFunding Update
14th Aug 20197:00 amRNSMOU with Merlin Energy Resources Ltd
12th Aug 20194:40 pmRNSSecond Price Monitoring Extn
12th Aug 20194:36 pmRNSPrice Monitoring Extension
12th Aug 201912:02 pmRNSPrice Monitoring Extension
12th Aug 20197:00 amRNSMemorandum of Agreement with European Oil Refiner
23rd Jul 201911:08 amRNSStmnt re Share Price Movement
10th Jul 20197:00 amRNSDirector/PDMR Shareholding
3rd Jul 20197:00 amRNSPDMR Shareholding and Transfer of Share Options
27th Jun 20195:20 pmRNSIssue of Share Options
24th Jun 20194:40 pmRNSSecond Price Monitoring Extn
24th Jun 20194:35 pmRNSPrice Monitoring Extension
24th Jun 201911:41 amRNSAppointment of Joint Broker
13th Jun 20197:00 amRNSKSA Services Agreement and Grant of Warrants
11th Jun 20197:00 amRNSAgency Agreement for Mexico
30th May 20198:59 amRNSReplacement: MOA with Al Khafrah Holding Group
30th May 20197:00 amRNSMOU with Al Khafrah Holding Group
20th May 20193:00 pmRNSUpdate on Test Programme and Termination of MOA
15th May 20197:00 amRNSInvestor Conference Call
13th May 20197:00 amRNSMOU with API POLY-GCL Alliance
8th May 20193:23 pmRNSHolding(s) in Company
8th May 20197:00 amRNSKuwait Agency Agreement and MoU
23rd Apr 201911:40 amRNSDirectorate Change
27th Mar 20197:00 amRNSMemorandum of Understanding with Bitumina
25th Mar 20197:00 amRNSHalf-year Report
18th Mar 20194:40 pmRNSSecond Price Monitoring Extn
18th Mar 20194:35 pmRNSPrice Monitoring Extension
6th Mar 20197:00 amRNSRepresentation Agreement and Grant of Warrants
26th Feb 20197:00 amRNSKuwait Services Agreement & Grant of Warrants
13th Feb 20197:00 amRNSInvestor Site Visit
31st Jan 201912:00 pmRNSTotal Voting Rights
21st Jan 20197:00 amRNSResult of Open Offer
7th Jan 20195:11 pmRNSExtension of Open Offer Closing Date
12th Dec 20187:01 amRNSInvestor Conference Call
12th Dec 20187:00 amRNSChange of Adviser
7th Dec 20187:00 amRNSOpen Offer
30th Nov 20184:07 pmRNSResult of AGM
30th Nov 20187:00 amRNSCo-Marketing & Project Development Agreement
28th Nov 20187:00 amRNSMOU and MSAR® Test Programme
26th Nov 20187:00 amRNSExtension of Contracts with AkzoNobel

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.